 |
|
 |
|
      |
|
| |
|
|
Contact PIN Guidelines Writing Group
|
Current PIN Guidelines
Comments Received The dose range for administration might be better stated as 200-500 mg/kg every 3-4 weeks, as the IgG clearance in some patients is so low, and their clinical phenotype so mild, as to result in that lower dose being sufficient for their clinical needs. This will then serve to limit any unnecessary exposure to (the possible complications of) IVIG therapy. |
|||||||||
 |